In the independent intraductal papillary mucinous neoplasm (IPMN) cohort, 70.73% of cases expressed HHLA2, but this expression was not markedly related to IPMN grade. This evidence concerns the gene HHLA2 and pancreatic intraductal papillary-mucinous neoplasm.